Zacks Research Has Positive View of AstraZeneca Q2 Earnings
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Zacks Research boosted their Q2 2026 EPS estimates for shares of AstraZeneca in a research report issued on Tuesday, May 20th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $1.21 for the quarter, up from their previous estimate of $1.19. […]
